Erratum: The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence (Neuropsychopharmacology (2011) 36 (2339-2348) DOI: 10.1038/npp.2011.123);The neuropeptide galanin and variants in the galr1 gene are associated with nicotine dependence

Neuropsychopharmacology

Volumn 36, Issue 11, 2011, Pages 2339-2348

  Jackson, Kia J ^a   Chen, Xiangning ^a   Miles, Michael F ^b   Harenza, Jolynne ^b   Damaj, M Imad ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

BXD recombinant inbred strains; Galanin; galanin receptor 1 (GALR1); galnon; nicotine dependence; single nucleotide polymorphisms (SNPs)

Indexed keywords

GALANIN; GALANIN DERIVATIVE; GALANIN RECEPTOR 1; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; META ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 80052736717     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.95     Document Type: Erratum

References (45)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
2. Belfer I, Hipp H, Bollettino A, McKnight C, Evans C, Virkkunen M et al (2007). Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav 6: 473-481. (Pubitemid 47024960)
3. Belfer I, Hipp H, McKnight C, Evans C, Buzas B, Bollettino A et al (2006). Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11: 301-311.
4. Brigman JL, Mathur P, Lu L, Williams RW, Holmes A (2009). Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice. Behav Pharmacol 20: 204-209.
5. Caspi A, Moffitt TE (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7: 583-590. (Pubitemid 43995433)
6. Elliott RC, Miles MF, Lowenstein DH (2003). Overlapping microarray profiles of dentate gyrus gene expression during development-and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci 23: 2218-2227. (Pubitemid 36368910)
7. Engberg G, Hajos M (1994). Nicotine-induced activation of locus coeruleus neuronsFan analysis of peripheral versus central induction. Naunyn Schmiedebergs Arch Pharmacol 349: 443-446. (Pubitemid 24135123)
8. Ericson E, Ahlenius S (1999). Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmis-sion. Brain Res 822: 200-209. (Pubitemid 29222843)
9. Fu Y, Matta SG, James TJ, Sharp BM (1998). Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. J Pharmacol Exp Ther 284: 1188-1196. (Pubitemid 28130850)
10. Hawes JJ, Picciotto MR (2004). Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J Comp Neurol 479: 410-423. (Pubitemid 39453146)
11. Erratum in: J Comp Neurol (2005) 490:98-100.
12. Hildebrand BE, Panagis G, Svensson TH, Nomikos GG (1999). Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacol-ogy 21: 560-574. (Pubitemid 29414801)
13. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G (2003). Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24: 580-588. (Pubitemid 37357142)
14. Jackson KJ, Martin BR, Changeux JP, Damaj MI (2008). Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325: 302-312. (Pubitemid 351439184)
15. Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI (2009). Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology 57: 347-355.
16. Karatayev O, Baylan J, Weed V, Chang S, Wynick D, Leibowitz SF (2010). Galanin knockout mice show disturbances in ethanol consumption and expression of hypothalamic peptides that stimulate ethanol intake. Alcohol Clin Exp Res 34: 72-80.
17. Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-184.
18. Koob GF (2008). A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
19. Koob GF, Le Moal M (2008). Addiction and the brain antireward system. Annu Rev Psychol 59: 29-53.
20. Kota D, Martin BR, Robinson SE, Damaj MI (2007). Nicotine dependence and reward differ between adolescent and adult mice. J Pharmacol Exp Ther 322: 399-407. (Pubitemid 46956383)
21. Kuteeva E, Hökfelt T, Ogren SO (2005). Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter. Regul Pept 125: 67-78. (Pubitemid 39593710)
22. Leibowitz SF (2005). Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides 39: 327-332. (Pubitemid 40804606)
23. Lori Am Tang Y, O'Malley S, Picciotto MR, Wu R, Conneely KN, Cubells JF (2011) The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. Neuropsychopharacology, in press (published online 23 March 2011 at www.nature.com/npp/journal/vaop/ncurrent/full/npp201125a.html ).
24. Magi R, Morris AP (2010). GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11: 288.
25. Mennicken F, Hoffert C, Pelletier M, Ahmad S, O'Donnell D (2002). Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat 24: 257-268. (Pubitemid 35291193)
26. Mozhui K, Hamre KM, Holmes A, Lu L, Williams RW (2007). Genetic and structural analysis of the basolateral amygdala complex in BXD recombinant inbred mice. Behav Genet 37: 223-243. (Pubitemid 46144058)
27. Narasimhaiah R, Kamens HM, Picciotto MR (2009). Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice. Psychopharmacology (Berl) 204: 95-102.
28. Neugebaur NM, Henehan RM, Hales CA, Picciotto MR (2011). Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav 98: 87-93.
29. Neumann PE, Garretson JD, Skabardonis GP, Mueller GG (1993). Genetic analysis of cerebellar folial pattern in crosses of C57BL/6J and DBA/2J inbred mice. Brain Res 619: 81-88. (Pubitemid 23214308)
30. Picciotto MR (2008). Galanin and addiction. Cell Mol Life Sci 65: 1872-1879.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. (Pubitemid 47330214)
32. Rada P, Avena NM, Leibowitz SF, Hoebel BG (2004). Ethanol intake is increased by injection of galanin in the para-ventricular nucleus and reduced by a galanin antagonist. Alcohol 33: 91-97. (Pubitemid 39441047)
33. Rustay NR, Wrenn CC, Kinney JW, Holmes A, Bailey KR, Sullivan TL et al (2005). Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides 39: 239-243. (Pubitemid 40804591)
34. Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K et al (2002). Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci USA 99: 7136-7141. (Pubitemid 34526268)
35. Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X, Cichon S et al (2010). Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 6:pii: e1001053.
36. Salas R, Pieri F, De Biasi M (2004). Decreased signs of nicotine withdrawal in mice null for the b4 nicotinic acetylcholine receptor subunit. J Neurosci 24: 10035-10039. (Pubitemid 39492026)
37. Sara SJ (2009). The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10: 211-223.
38. Scheet P, Stephens M (2006). A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78: 629-644.
39. Sollenberg U, Bartfai T, Langel U (2005). GalnonFa low-molecular weight ligand of the galanin receptors. Neuropeptides 39: 161-163. (Pubitemid 40804578)
40. Svensson TH, Engberg G (1980). Effect of nicotine on single cell activity in the noradrenergic nucleus locus coeruleus. Acta Physiol Scand Suppl 479: 31-34. (Pubitemid 11247884)
41. Tsuda K, Tsuda S, Nishio I, Masuyama Y, Goldstein M (1998). Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am J Hypertens 11: 1475-1479. (Pubitemid 29030313)
42. Wang S, Hashemi T, Fried S (1998). Differential intracellular signaling of the GALR1 and GALR2 galanin receptor subtypes. Biochemistry 37: 6711-6717. (Pubitemid 28228104)
43. Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA et al (2003). The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci USA 100: 9028-9033. (Pubitemid 36899217)
44. Zachariou V, Parikh K, Picciotto MR (1999). Centrally administered galanin blocks morphine place preference in the mouse. Brain Res 831: 33-42. (Pubitemid 29336185)
45. Zachariou V, Thome J, Parikh K, Picciotto MR (2000). Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology 23: 127-137. (Pubitemid 30406897)